Q4/2024 12/31/2024 EPS -0.550 ZacksConsensus -0.680 ActVsEst 0.130 - Beat
ALX Oncology Holdings Inc. (ALXO)
Company Research
Source: Wall Street Horizon
Impact Snapshot
Event Time:
ALXO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALXO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALXO alerts
High impacting ALX Oncology Holdings Inc. news events
Weekly update
A roundup of the hottest topics
ALXO
News
- ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate [Yahoo! Finance]Yahoo! Finance
- ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug ConjugateGlobeNewswire
- TOLREMO Strengthens Scientific Advisory Board with Lung Cancer Expert Pasi A. Jänne [Yahoo! Finance]Yahoo! Finance
- ALX Oncology to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 [Yahoo! Finance]Yahoo! Finance
- Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the ChargePR Newswire
ALXO
Earnings
- 3/6/25 - Beat
ALXO
Sec Filings
- 3/18/25 - Form 4
- 3/18/25 - Form 4
- 3/6/25 - Form S-3
- ALXO's page on the SEC website